Luce Emerson

Luce Emerson

InvestorPlace Contributor

Luce Emerson is a former sell-side banker with a broad range of capital markets experience. She continues to follow markets closely, with a particular focus on retail, financials and entertainment.

Recent Articles

Even After Nio Stock Price Halved, It’s Still Not Cheap Enough To Buy Now

By Luce Emerson, InvestorPlace Contributor

Based on the outlook given by management, it would be foolish for anyone to think that the Nio stock future is anything close to rosy.

This Is Why LYFT Stock Is a Better Buy Than Uber Stock

By Luce Emerson, InvestorPlace Contributor

Uber stock only will continue to disappoint, whereas Lyft stock appears to have settled into a place where it is ready to grow.

3 Beaten-Down Travel Stocks to Buy Now

By Luce Emerson, InvestorPlace Contributor

Travel stocks have not been a part of the rally this year, but all evidence points to them still being solid stocks to buy for the long term.

In the War for Your Digital Wallet, Bet on Tech Stocks All the Way

By Luce Emerson, InvestorPlace Contributor

Overall, in the battle for the the digital wallet, SQ stock and PYPL stock look like buys here. Banks inherently aren't as nimble as tech companies. SQ and PYPL have edge in designing user interfaces and smaller but more loyal customer bases. While the mere fact of startups encroaching on bank payments is not enough to warrant a sell on big bank stocks, it's not a favorable trend.

Canopy Growth’s M&A Strategy Is a Good Bet

By Luce Emerson, InvestorPlace Contributor

After a strong first quarter and with M&A activity on the rise, CGC stock could break out in the second half of the year. Here's what to expect from Canopy Growth.

It’s About Time to Stop Fighting the Netflix Stock Trend

By Luce Emerson, InvestorPlace Contributor

Sometimes, the best investment is the one that just goes with the trend. For all that contrarian investors have tried to explain that Netflix, Inc. (NASDAQ:NFLX) valuation is stretched, that it’s time is up, Netflix stock has continued higher.

Two Healthcare Stocks in the XLV Fund Stand Out

By Luce Emerson, InvestorPlace Contributor

MRK stock and ABBV stock are promising healthcare stocks to invest in from the XLV fund. MRK is 6% of holdings and AbbVie makes up 3.5%.

With Its Rivian Investment, the Future Looks Bright for Ford Stock

By Luce Emerson, InvestorPlace Contributor

Ford Motor Company (NYSE:F) has rewarded patient shareholders with a strong start to 2019. The Company has also demonstrated its willingness to make necessary changes to stay at the forefront of innovation.

The Future Keeps Looking Brighter and Brighter for Zoom Stock

By Luce Emerson, InvestorPlace Contributor

Zoom Video Communications Inc (NASDAQ:ZM) may be the most promising tech IPO to date. The fact that it’s actually profitable is certainly a contributing factor but not the only one. In addition to being net income positive, this San Jose-based communications company, has a lot going in its favor.

Lululemon Stock Rides Brand’s Climb To Top Athletic Apparel Spot

By Luce Emerson, InvestorPlace Contributor

Lululemon Athletica has seen its share of bears. LULU stock and the brand fueling it continue to prove them wrong.

Load More